News & Updates

Show Multimedia Only

Surgery, mechanical aspiration do not prevent death in tricuspid valve infective endocarditis

24 Sep 2024

Valve surgery or percutaneous mechanical aspiration, in combination with medical therapy, fall short of providing survival benefits to patients with isolated tricuspid valve infective endocarditis, results of a study have shown. However, addiction medicine consultation appears to be protective against the risk of death at 1 year in this population.

Surgery, mechanical aspiration do not prevent death in tricuspid valve infective endocarditis

24 Sep 2024

Late recovery of LV function tied to poor survival in patients with Takotsubo syndrome

23 Sep 2024

In patients with Takotsubo syndrome (TTS), late recovery of left ventricular (LV) function appears to contribute to reduced short- and long-term survival, suggests a study.

Late recovery of LV function tied to poor survival in patients with Takotsubo syndrome

23 Sep 2024

IBD patients at high myocarditis risk for up to 20 years

21 Sep 2024

The risk of myocarditis appears to be elevated among patients with inflammatory bowel disease (IBD) for ≥20 years following diagnosis, suggests a study in Sweden. However, absolute risks remain low.

IBD patients at high myocarditis risk for up to 20 years

21 Sep 2024

Culturally adapted lifestyle intervention no better than written materials for CVD risk reduction

19 Sep 2024

Among South Asian adults, a culturally adapted, group-based lifestyle intervention does not appear to result in greater improvements in cardiovascular disease (CVD) risk factors as compared with written health education materials, according to the SAHELI study.

Culturally adapted lifestyle intervention no better than written materials for CVD risk reduction

19 Sep 2024

Pre-cath lab: To fast or not?

19 Sep 2024 by

The SCOFF* trial presented at ESC 2024 shows that fasting is not necessary prior to cardiac catheterization procedures requiring conscious sedation.

Pre-cath lab: To fast or not?

19 Sep 2024

Evogliptin does not ease AV calcification, but longer use holds promise

18 Sep 2024

Treatment with evogliptin falls short of providing protective benefits against calcification of the aortic valve (AV), but longer treatment may be helpful, reports a study.

Evogliptin does not ease AV calcification, but longer use holds promise

18 Sep 2024

Single, triple-combo pill hits BP target in two phase III trials

18 Sep 2024 by

GMRx2, a novel low-dose single pill containing three antihypertensive drugs – telmisartan, amlodipine, and indapamide – achieves all efficacy endpoints in two pivotal phase III trials presented at ESC 2024.

Single, triple-combo pill hits BP target in two phase III trials

18 Sep 2024

Vutrisiran may improve outcomes in transthyretin amyloidosis with cardiomyopathy

17 Sep 2024

In patients with transthyretin amyloidosis with cardiomyopathy (ATTR-CM), treatment with vutrisiran appears to reduce the risk of death from any cause and cardiovascular events while preserving functional capacity and quality of life, as shown in a study.

Vutrisiran may improve outcomes in transthyretin amyloidosis with cardiomyopathy

17 Sep 2024

HELIOS-B shines on vutrisiran for ATTR-CM

16 Sep 2024 by

In the phase III HELIOS-B trial, vutrisiran reduced death and cardiovascular (CV) events in patients with transthyretin amyloidosis with cardiomyopathy (ATTR-CM).

HELIOS-B shines on vutrisiran for ATTR-CM

16 Sep 2024

NOACs better than VKAs at preventing deaths, CVD in AF patients with or without impaired kidney

15 Sep 2024 by

For atrial fibrillation (AF) patients with normal or impaired renal function, use of nonvitamin K antagonist oral anticoagulants (NOACs) results in improved outcomes relative to vitamin K antagonist (VKA) therapy, suggests a study presented at ESC 2024.

NOACs better than VKAs at preventing deaths, CVD in AF patients with or without impaired kidney

15 Sep 2024

News & Updates

Showing Cardiology articles

Showing

Specialty:

Surgery, mechanical aspiration do not prevent death in tricuspid valve infective endocarditis

Surgery, mechanical aspiration do not prevent death in tricuspid valve infective endocarditis

Late recovery of LV function tied to poor survival in patients with Takotsubo syndrome

Late recovery of LV function tied to poor survival in patients with Takotsubo syndrome

IBD patients at high myocarditis risk for up to 20 years

IBD patients at high myocarditis risk for up to 20 years

Culturally adapted lifestyle intervention no better than written materials for CVD risk reduction

Culturally adapted lifestyle intervention no better than written materials for CVD risk reduction

Pre-cath lab: To fast or not?

Pre-cath lab: To fast or not?

Evogliptin does not ease AV calcification, but longer use holds promise

Evogliptin does not ease AV calcification, but longer use holds promise

Single, triple-combo pill hits BP target in two phase III trials

Single, triple-combo pill hits BP target in two phase III trials

Vutrisiran may improve outcomes in transthyretin amyloidosis with cardiomyopathy

Vutrisiran may improve outcomes in transthyretin amyloidosis with cardiomyopathy

HELIOS-B shines on vutrisiran for ATTR-CM

HELIOS-B shines on vutrisiran for ATTR-CM

NOACs better than VKAs at preventing deaths, CVD in AF patients with or without impaired kidney

NOACs better than VKAs at preventing deaths, CVD in AF patients with or without impaired kidney